Evidence map›Paper›PMID 38559181›Full record

ArticlebioRxiv : the preprint server for biology2025

Cell Marker Accordion: interpretable single-cell and spatial omics annotation in health and disease.

Emma Busarello, Giulia Biancon, Ilaria Cimignolo, Fabio Lauria, Zuhairia Ibnat, Christian Ramirez, Gabriele Tomè, Marianna Ciuffreda, Giorgia Bucciarelli, Alessandro Pilli and 12 more

Open access · greenAbstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 5 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

22 authors at 3 institutions in 3 countries.

Emma BusarelloLaboratory of RNA and Disease Data Science, Department of Cellular, Computational and Integrative Biology (CIBIO), University of Trento, Trento, Italy.ORCID 0009-0009-7731-9777
Giulia BianconSection of Hematology, Department of Internal Medicine, Yale Comprehensive Cancer Center, Yale University School of Medicine, New Haven, CT, USA.ORCID 0000-0003-0182-7766
Ilaria CimignoloLaboratory of RNA and Disease Data Science, Department of Cellular, Computational and Integrative Biology (CIBIO), University of Trento, Trento, Italy.ORCID 0009-0001-9330-7022
Fabio LauriaInstitute of Biophysics, CNR Unit at Trento, Italy.ORCID 0000-0002-3314-8429
Zuhairia IbnatLaboratory of RNA and Disease Data Science, Department of Cellular, Computational and Integrative Biology (CIBIO), University of Trento, Trento, Italy.
Christian RamirezLaboratory of RNA and Disease Data Science, Department of Cellular, Computational and Integrative Biology (CIBIO), University of Trento, Trento, Italy.ORCID 0009-0005-9076-9757
Gabriele TomèLaboratory of RNA and Disease Data Science, Department of Cellular, Computational and Integrative Biology (CIBIO), University of Trento, Trento, Italy.ORCID 0000-0002-3976-6068
Marianna CiuffredaLaboratory of RNA and Disease Data Science, Department of Cellular, Computational and Integrative Biology (CIBIO), University of Trento, Trento, Italy.ORCID 0009-0002-6946-0040
Giorgia BucciarelliLaboratory of RNA and Disease Data Science, Department of Cellular, Computational and Integrative Biology (CIBIO), University of Trento, Trento, Italy.ORCID 0009-0000-3683-7994
Alessandro PilliLaboratory of RNA and Disease Data Science, Department of Cellular, Computational and Integrative Biology (CIBIO), University of Trento, Trento, Italy.ORCID 0009-0009-1545-7533
Stefano Maria MarinoLaboratory of RNA and Disease Data Science, Department of Cellular, Computational and Integrative Biology (CIBIO), University of Trento, Trento, Italy.ORCID 0000-0002-3613-724X
Vittorio BontempiLaboratory of Experimental Cancer Biology, Department of Cellular, Computational and Integrative Biology (CIBIO), University of Trento, Trento, Italy.ORCID 0009-0009-7583-4265
Federica RessArmenise-Harvard Laboratory of Brain Disorders and Cancer, Department of Cellular, Computational and Integrative Biology (CIBIO), University of Trento, Trento, Italy.ORCID 0009-0004-4583-2086
Kristin R AassDepartment of Clinical and Molecular Medicine, Norwegian University of Science and Technology (NTNU), Trondheim, Norway.ORCID 0000-0002-7513-4826
Jennifer VanOudenhoveSection of Hematology, Department of Internal Medicine, Yale Comprehensive Cancer Center, Yale University School of Medicine, New Haven, CT, USA.ORCID 0000-0001-8206-5542
Luca TiberiArmenise-Harvard Laboratory of Brain Disorders and Cancer, Department of Cellular, Computational and Integrative Biology (CIBIO), University of Trento, Trento, Italy.
Maria Caterina MioneLaboratory of Experimental Cancer Biology, Department of Cellular, Computational and Integrative Biology (CIBIO), University of Trento, Trento, Italy.
Therese StandalDepartment of Clinical and Molecular Medicine, Norwegian University of Science and Technology (NTNU), Trondheim, Norway.ORCID 0000-0003-3314-8522
Paolo MacchiLaboratory of Molecular and Cellular Neurobiology, Department of Cellular, Computational and Integrative Biology (CIBIO), University of Trento, Trento, Italy.ORCID 0000-0002-7245-9019
Gabriella VieroInstitute of Biophysics, CNR Unit at Trento, Italy.ORCID 0000-0002-6755-285X
Stephanie HaleneSection of Hematology, Department of Internal Medicine, Yale Comprehensive Cancer Center, Yale University School of Medicine, New Haven, CT, USA.ORCID 0000-0002-2737-9810
Toma TebaldiLaboratory of RNA and Disease Data Science, Department of Cellular, Computational and Integrative Biology (CIBIO), University of Trento, Trento, Italy.ORCID 0000-0002-0625-1631
University of Trento · ITYale Cancer Center · USNorwegian University of Science and Technology · NO

Funding

Yale Cooperative Hematology Specialized Core CenterU54DK106857 · NIDDK · YALE UNIVERSITY · PI JOHN HWA, Diane S Krause · 2015 to 2026
$9.7M
Center for Human Lymphoma Spatiotemporal Atlas (HuLymSTA)U01CA294514 · NCI · YALE UNIVERSITY · PI FAN, RONG, HALENE, STEPHANIE · 2024 to 2025
$5.1M
Targeting Defective DNA Damage Response Pathways in IDH1/2-mutant AMLR01CA266604 · NCI · YALE UNIVERSITY · PI Ranjit Bindra, Stephanie Halene · 2022 to 2026
$3.3M
Mechanisms of Leukemogenesis in AMKLR01CA222518 · NCI · YALE UNIVERSITY · PI HALENE, STEPHANIE, KRAUSE, DIANE S · 2020 to 2024
$3.0M
Modeling myelodysplasiaR01CA253981 · NCI · CINCINNATI CHILDRENS HOSP MED CTR · PI GRIMES, H. LEIGHTON, HALENE, STEPHANIE · 2021 to 2025
$2.9M
The role of m6A RNA modification as modulator of dsRNA induced cell-intrinsic innate immune responses in hematopoiesisR01DK124788 · NIDDK · YALE UNIVERSITY · PI HALENE, STEPHANIE · 2021 to 2023
$884k
NCI NIH HHS R01 CA222518NCI NIH HHS R01 CA253981NCI NIH HHS R01 CA266604NCI NIH HHS U01 CA294514NIDDK NIH HHS R01 DK124788NIDDK NIH HHS U54 DK106857
6 · The paper itself

Abstract

Single-cell technologies offer a unique opportunity to explore cellular heterogeneity in health and disease. However, reliable identification of cell types and states represents a bottleneck. Available databases and analysis tools employ dissimilar markers, leading to inconsistent annotations and poor interpretability. Furthermore, current tools focus mostly on physiological cell types, limiting their applicability to disease. We developed the Cell Marker Accordion, a user-friendly platform providing automatic annotation and unmatched biological interpretation of single-cell populations, based on consistency weighted markers. We validated our approach on multiple single-cell and spatial datasets from different human and murine tissues, improving annotation accuracy in all cases. Moreover, we show that the Cell Marker Accordion can identify disease-critical cells and pathological processes, extracting potential biomarkers in a wide variety of disease contexts. The breadth of these applications elevates the Cell Marker Accordion as a fast, flexible, faithful and standardized tool to annotate and interpret single-cell and spatial populations in studying physiology and disease.

Identifiers

PMID38559181
PMCPMC10979856
OpenAlexW4392679418

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.